Status:

COMPLETED

Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

Lead Sponsor:

Organon and Co

Conditions:

Renal Disorder

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Antiproteinuric Efficacy of Losartan Potassium in Patients with Non-Diabetic Proteinuric Renal Diseases.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Males or females at least 18 years of age with non-diabetic proteinuric renal diseases

Exclusion

    Key Trial Info

    Start Date :

    February 1 2000

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2002

    Estimated Enrollment :

    97 Patients enrolled

    Trial Details

    Trial ID

    NCT00140985

    Start Date

    February 1 2000

    End Date

    January 1 2002

    Last Update

    February 16 2022

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.